insights_auto
Nega ONCY oshdi 2,31%?
Batafsil oʻrganishchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
0,56 US$
arrow_upward
+2,31%(+0,013) 1K
0,55 US$
arrow_downward
-1,26% (-0,0070)bedtimeYopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoONCY tikeri uchun statistika yaratilmoqda...
Ochish
0,55 US$
Yuqori
0,57 US$
Past
0,52 US$
Bozor kapitali
73,63 mln
Oʻrtacha hajm
1,05 mln
Hajmi
1,46 mln
52 haftalik eng yuqori
1,32 US$
52 haftalik eng past
0,52 US$
Beta
1,15
Muomaladagi aksiyalar
127,51 mln
Xodimlar soni
29
Ochish
0,55 US$
Yuqori
0,57 US$
Past
0,52 US$
Bozor kapitali
73,63 mln
Oʻrtacha hajm
1,05 mln
Hajmi
1,46 mln
52 haftalik eng yuqori
1,32 US$
52 haftalik eng past
0,52 US$
Beta
1,15
Muomaladagi aksiyalar
127,51 mln
Xodimlar soni
29
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
9 daqiqa oldin
SPINOZA Trial Start Could Be A Game Changer For NewAmsterdam Pharma Stock (NAMS)
The Globe and Mail
·
8 daqiqa oldin
Kaplan Fox Reminds Investors of Duolingo, Inc. (NASDAQ: DUOL) to a Securities Class Action Deadline - Contact the Firm Before December 7, 2026
Mitrade
·
14 daqiqa oldin
Current S&P 500 Bull Market Turns 4 Monday and History Suggests More to Come
Nasdaq
·
13 soat oldin
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profil
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Oncolytics Biotech Inc haqida
CEO-
Xodimlar soni29
Asos solingan1998
Bosh ofislarKalgari, Alberta, Kanada
Sektor-
Veb-saytoncolyticsbiotech.com